PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
20709795-0	2010	Resveratrol prevents light-induced retinal degeneration via suppressing activator protein-1 activation.	Resveratrol	0-11	jun proto-oncogene	Mus musculus	72-91	
24073240-6	2013	The acetylation of c-Jun decreased and its translocation was impeded in the resveratrol-treated T cells.	Resveratrol	76-87	jun proto-oncogene	Mus musculus	19-24	
20709795-8	2010	Retinal activator protein-1 activation, up-regulated following light exposure, was significantly reduced by application of resveratrol.	Resveratrol	123-134	jun proto-oncogene	Mus musculus	8-27	
18551458-0	2008	Pterostilbene is equally potent as resveratrol in inhibiting 12-O-tetradecanoylphorbol-13-acetate activated NFkappaB, AP-1, COX-2, and iNOS in mouse epidermis.	Resveratrol	35-46	jun proto-oncogene	Mus musculus	118-122	
20712904-10	2010	Resveratrol inhibited LPS-induced NF-kappaB activation in both cell types, but inhibited AP-1 activation only in microglia.	Resveratrol	0-11	jun proto-oncogene	Mus musculus	89-93	
18551458-4	2008	Resveratrol and pterostilbene significantly reduced activator protein 1 (AP-1) and NF-kappaB activation.	Resveratrol	0-11	jun proto-oncogene	Mus musculus	52-71	
18551458-4	2008	Resveratrol and pterostilbene significantly reduced activator protein 1 (AP-1) and NF-kappaB activation.	Resveratrol	0-11	jun proto-oncogene	Mus musculus	73-77	
15630167-0	2004	Resveratrol inhibits phorbol ester-induced cyclooxygenase-2 expression in mouse skin: MAPKs and AP-1 as potential molecular targets.	Resveratrol	0-11	jun proto-oncogene	Mus musculus	96-100	
16999939-0	2006	Resveratrol modulates phorbol ester-induced pro-inflammatory signal transduction pathways in mouse skin in vivo: NF-kappaB and AP-1 as prime targets.	Resveratrol	0-11	jun proto-oncogene	Mus musculus	127-131	
15630167-7	2004	In addition, resveratrol prevented TPA-induced DNA binding of activator protein-1 (AP-1).	Resveratrol	13-24	jun proto-oncogene	Mus musculus	62-81	
15630167-7	2004	In addition, resveratrol prevented TPA-induced DNA binding of activator protein-1 (AP-1).	Resveratrol	13-24	jun proto-oncogene	Mus musculus	83-87	
15630167-8	2004	Taken together, suppression of COX-2 expression by blocking the activation of MAPKs and AP-1 may represent possible molecular mechanisms responsible for previously reported anti-tumor promoting effects of resveratrol on mouse skin carcinogenesis.	Resveratrol	205-216	jun proto-oncogene	Mus musculus	88-92	
26100520-4	2015	The combination of ursolic acid + resveratrol inhibited TPA-induced signaling pathways, including EGFR, STAT3, Src, Akt, Cox-2, Fas, NF-kappaB, p38 MAPK, c-Jun, and JNK1/2 while increasing levels of tumor suppressors, such as p21 and PDCD4, to a greater extent compared with the groups treated with the individual compounds.	Resveratrol	34-45	jun proto-oncogene	Mus musculus	154-159	
26100520-7	2015	Furthermore, NF-kappaB, Egr-1, and AP-1 DNA binding activities after TPA treatment were dramatically decreased by the combination of ursolic acid + resveratrol.	Resveratrol	148-159	jun proto-oncogene	Mus musculus	35-39	
10370867-9	1999	As judged by the reverse transcriptase-polymerase chain reaction, resveratrol selectively inhibited TPA-induced expression of c-fos and transforming growth factor-beta 1 (TGF-beta 1), but did not affect other TPA-induced gene products including COX-1, COX-2, c-myc, c-jun, and tumor necrosis factor-alpha.	Resveratrol	66-77	jun proto-oncogene	Mus musculus	266-271	
31844893-0	2020	Resveratrol attenuates diabetes-associated cell centrosome amplification via inhibiting the PKCalpha-p38 to c-myc/c-jun pathway.	Resveratrol	0-11	jun proto-oncogene	Mus musculus	114-119	
31844893-11	2020	Interestingly, resveratrol, but not metformin, was able to attenuate the treatment-induced increase in the levels of p-PKCalpha, p-p38, c-myc, and c-jun, as well as the centrosome amplification.	Resveratrol	15-26	jun proto-oncogene	Mus musculus	147-152	
28511554-6	2017	In the present study, we show that resveratrol could upregulate the expressions of NF-kappaB, IkappaB kinase, JNK, and c-jun in splenic lymphocytes of immunosuppressive mice.	Resveratrol	35-46	jun proto-oncogene	Mus musculus	119-124